EEG Results of Deep TMS in Patients With OCD
Obsessive-Compulsive Disorder, EEG With Periodic Abnormalities
About this trial
This is an interventional treatment trial for Obsessive-Compulsive Disorder focused on measuring Obsessive compulsive disorder, Deep Transcranial Magnetic Stimulation, Mood, Quality of Life, EEG
Eligibility Criteria
Inclusion Criteria:
- Being diagnosed with Obsessive Compulsive Disorder within the framework of DSM-5 criteria
Exclusion Criteria:
- Not volunteering to comply with the research program
- Presence of a metal piece on the head
- Having a pacemaker inserted
- Having had a previous epileptic seizure
Sites / Locations
- Istanbul Medipol University
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Active Comparator
Deep Transcranial Magnetic Stimulation
Deep Transcranial Magnetic Stimulation and Paroxetine
Paroxetine
The treatment will be carried out for 6 weeks, 5 days a week, in total 30 sessions; 20 hz using Brainsway H-7 helmet. It will be applied to the mPFC and ACC simultaneously with a total of 2000 beats at a frequency of 50 beats in each string.
The treatment will be carried out for 6 weeks, 5 days a week, in total 30 sessions; 20 hz using Brainsway H-7 helmet. It will be applied to the mPFC and ACC simultaneously with a total of 2000 beats at a frequency of 50 beats in each string. In addtion to DTMMS, paroxetine will applied.
Paroxetine is a type of antidepressant known as an SSRI (selective serotonin reuptake inhibitor). It's often used to treat depression in OCD.